Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Thumbnail

FDA announces recall of nearly 700 embolic protection devices after multiple malfunctions

The device's filter is breaking off during the retrieval process, making it much more difficult to withdraw. 

Just 1 month of DAPT after PCI shows promise, new meta-analysis confirms

Researchers evaluated data from four different studies, sharing their results in the American Journal of Cardiology.

What new research tells us about distal transradial vs. transradial access for coronary procedures

The distal transradial approach is associated with some key benefits—but there does appear to be room for improvement. 

Thumbnail

Among patients with premature ASCVD, women more likely to report poor physical, mental health

Adults with premature ASCVD, particularly women, may benefit from better access to mental health services as well as interventions that address out-of-pocket costs.

Thumbnail

Recent marijuana use increases risk of serious stroke complication

The study's authors believe this to be the largest analysis to date to look at the impact of THC on aneurysmal subarachnoid hemorrhage complications. 

Thumbnail

Viagra may worsen abdominal aortic aneurysms, new research shows

While additional research is still needed, these findings suggest that sildenafil may need to be limited among patients with a history of abdominal aortic aneurysms.

Thumbnail

An industry first: FDA authorizes marketing of laser-assisted IVC filter removal device

The Philips CavaClear Laser Sheath earned the agency’s breakthrough device designation back in July.

Thumbnail

FDA approves rivaroxaban for treating, preventing blood clots in pediatric patients

The direct oral anticoagulant is now approved for 11 different indications. 

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.